Skip to main content
Premium Trial:

Request an Annual Quote

Enzymatics, UT-Austin Develop Room Temp-Stable NGS Library Construction Kits

Premium

Enzymatics said recently that it has collaborated with scientists from the University of Texas, Austin, to develop a portfolio of room temperature-stable library construction kits for Illumina's sequencing platforms.

In addition, Enzymatics said it is working with UT-Austin to develop similar kits for Life Tech's Ion Torrent sequencing platforms.

The Beverly, Mass.-based company said that the room temperature-stable kits feature lyophilized reagent mixes that are precisely aliquoted and QC tested. Lyophilization enables the kits to be stored at ambient temperatures, eliminating the need for dry ice shipping, freezer storage, and lab bench ice buckets, Enzymatics said.

A spokesperson for the company said that the kits have been validated on the Illumina MiSeq and HiSeq, and that validation on the Ion Torrent PGM and Proton are currently in progress.

Enzymatics said that it has filed patents on the technology and is seeking commercialization partners.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more